Hypothesis: it is easier to hire all-star employees in bio than in tech

1- No FAANG golden handcuffs.

The Pharmas pretty ubiquitously suck to work at, the HQs lack the bells and whistles of tech, and pay for junior people is easily matched by a startup
2- Less founder culture in bio.

Bad for creating new bio co's, but great for hiring. Scientists are much more likely to look for a job than try to start a company
3- Less competition.

The activation energy to start a bio co is higher than tech, so fewer make it out of the gate. [does anyone have #s on this? this is an educated guess]

You can't do much in (traditional) bio without at least $100K

Less co's = less competition for talent
4 - Very specific mission motivation.

Some scientists spend 10+ years specializing in an area of bio. If you are also building in that area, the match is evident

(this has been a huge lever for us)

This is AFAIK less common in tech
Bio founders, employees - do you agree/disagree/have variables to add? cc @kamens @ntilmans

thanks @danielgross for the inspo w/ your founder hiring article dcgross.com/the-human-perf…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Celine Halioua

Celine Halioua Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @celinehalioua

12 Jul 20
Building a biotech company in Silicon Valley is amazing, but I quickly learned to not take common startup-isms at face value & to validate for myself that they translate over to building in bio. Many don't. Here's some differences I've noticed so far: celinehh.com/tech-vs-biotech
& a few faves:

TECH: Rolling derisking, early signs of product-market fit
BIOTECH: Derisking comes in bursts over years (biological milestones), early signals less reliable

TECH: Outsourcing product development or engineering unadvisable
BIOTECH: Common to use contractors
TECH: Can create a new market
BIOTECH: Markets are diseases and therefore public domain

TECH: Markets are winner-take-all
BIOTECH: Many winners
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!